Health
RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19 – News-Medical.Net
A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID…
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients. A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases. The results of the study were published in the Anaerobe jour…
-
Noosa News18 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News20 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News16 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win